KATNAL1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.299800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.744800E-01
Normal-vs-Stage2
2.430000E-01
Normal-vs-Stage3
1.275510E-02
Normal-vs-Stage4
9.871800E-01
Stage1-vs-Stage2
6.822400E-01
Stage1-vs-Stage3
1.607450E-01
Stage1-vs-Stage4
5.417400E-01
Stage2-vs-Stage3
1.526220E-01
Stage2-vs-Stage4
1.775030E-01
Stage3-vs-Stage4
1.300200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.199400E-01
Normal-vs-AfricanAmerican
3.068200E-01
Normal-vs-Asian
9.448400E-02
Caucasian-vs-AfricanAmerican
8.133800E-01
Caucasian-vs-Asian
1.295610E-01
AfricanAmerican-vs-Asian
3.931400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.449400E-01
Normal-vs-Female
4.183200E-01
Male-vs-Female
8.054000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.462570E-01
Normal-vs-Age(41-60Yrs)
7.155600E-01
Normal-vs-Age(61-80Yrs)
3.779600E-01
Normal-vs-Age(81-100Yrs)
4.978100E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.566200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.511000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.633200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.715900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.576280E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.850800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.046840E-01
Normal-vs-Daily Drinker
5.564200E-02
Normal-vs-Weekly Drinker
1.117630E-01
Normal-vs-Occasional Drinker
9.459800E-01
Normal-vs-Social Drinker
8.917600E-01
Non Drinker-vs-Daily Drinker
9.360400E-01
Non Drinker-vs-Weekly Drinker
8.578400E-01
Non Drinker-vs-Occasional Drinker
6.364400E-02
Non Drinker-vs-Social Drinker
1.208640E-01
Daily Drinker-vs-Weekly Drinker
7.927000E-01
Daily Drinker-vs-Occasional Drinker
5.731600E-02
Daily Drinker-vs-Social Drinker
1.116410E-01
Weekly Drinker-vs-Occasional Drinker
9.473800E-02
Weekly Drinker-vs-Social Drinker
1.620210E-01
Occasional Drinker-vs-Social Drinker
9.040600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.058600E-01
Normal-vs-Grade 2
4.843500E-02
Normal-vs-Grade 3
1.128980E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.715600E-01
Grade 1-vs-Grade 3
8.498400E-01
Grade 1-vs-Grade 4
2.058600E-01
Grade 2-vs-Grade 3
7.351000E-01
Grade 2-vs-Grade 4
4.843500E-02
Grade 3-vs-Grade 4
1.128980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.518200E-01
Normal-vs-NonDiabetic
4.553400E-01
Diabetic-vs-NonDiabetic
4.356000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.567000E-01
Normal-vs-NoPancreatitis
4.265600E-01
Pancreatitis-vs-NoPancreatitis
9.974000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.383800E-01
Normal-vs-N1
2.366200E-01
N0-vs-N1
1.958010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.557200E-01
Normal-vs-TP53-NonMutant
5.957600E-01
TP53-Mutant-vs-TP53-NonMutant
7.141000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
